Sure there are people who want a cure to be found. The problem (and not just for ear-related diseases): When you're a VP of Research and you are allotting the

Sure there are people who want a cure to be found. The problem (and not just for ear-related diseases): When you're a VP of Research and you are allotting the research budget or acquisition budget, do you go with prospect of a single pill cure or the lifelong treatment? The ROI on those two cases are likely very different.